Table 1. The resistance patterns of some bacteria with respect to patient location, gender and age group.
Gender | ||||
Microorganism | Female %(n) | Male %(n) | p value | Drug |
Coliform | 26.8 (40/149) | 43.2 (65/149) | 0.004 | Nalidixic acid |
Enterobacter species | 42.9 (9/21) | 0 (0/21) | 0.017 | Ceftazidime |
Proteus species | 54.2 (13/24) | 20.8 (5/24) | 0.028 | Nalidixic acid |
Location | ||||
Microorganism | Inpatient %(n) | Outpatient %(n) | p value | Drug |
Coliform | 28.1 (39/139) | 12.2 (17/139) | 0.014 | Nitrofurantoin |
CoNS | 40.7 (11/27) | 7.5 (2/27) | 0.031 | Ceftazidime |
Streptococcus species | 30 (6/20) | 0 (0/20) | 0.024 | Nitrofurantoin |
Klebsiella species | 45 (9/20) | 0 (0/20) | 0.004 | Chloramphenicol |
CoNS: coagulase negative Staphylococci, n: number, %: percent.